Sapir Alex
Insider CIK 1709415 · PHAS Director · FULC See Remarks, Director · DOVA President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 650,000 | — | $0 | 650,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2025-01-24 | 2025-01-28 | 582,000 | — | $0 | 582,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2024-07-03 | 2024-07-08 | 150,000 | — | $0 | 2,280,400 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2024-07-03 | 2024-07-08 | 150,000 | $3.27 | $490.5K | 193,360 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2024-03-04 | 2024-03-05 | 43,360 | $11.35 | $492.1K | 43,360 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 3,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-06-03 | 2021-06-04 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-06-03 | 2020-06-05 | 4,909 | — | $0 | 4,909 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-02-12 | 2020-02-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-08-14 | 2018-08-15 | 21,700 | $22.83 | $495.4K | 21,700 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | M Exercise deriv | 2017-12-22 | 2017-12-27 | 26,809 | — | $0 | 887,291 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | M Exercise | 2017-12-22 | 2017-12-27 | 26,809 | $3.73 | $100.0K | 46,909 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-07-05 | 2017-07-07 | 20,100 | $17.00 | $341.7K | 20,100 | SEC↗ |